Skip to main content

Mesenchymal stem cells in obesity: insights for translational applications.

Publication ,  Journal Article
Matsushita, K; Dzau, VJ
Published in: Lab Invest
October 2017

Obesity is now a major public health problem worldwide. Lifestyle modification to reduce the characteristic excess body adiposity is important in the treatment of obesity, but effective therapeutic intervention is still needed to control what has become an obesity epidemic. Unfortunately, many anti-obesity drugs have been withdrawn from market due to adverse side effects. Bariatric surgery therefore remains the most effective therapy for severe cases, although such surgery is invasive and researchers continue to seek new control strategies for obesity. Mesenchymal stem cells (MSCs) are a major source of adipocyte generation, and studies have been conducted into the potential roles of MSCs in treating obesity. However, despite significant progress in stem cell research and its potential applications for obesity, adipogenesis is a highly complex process and the molecular mechanisms governing MSC adipogenesis remain ill defined. In particular, successful clinical application of MSCs will require extensive identification and characterization of the transcriptional regulators controlling MSC adipogenesis. Since obesity is associated with the incidence of multiple important comorbidities, an in-depth understanding of the relationship between MSC adipogenesis and the comorbidities of obesity is also necessary to evaluate the potential of effective and safe MSC-based therapies for obesity. In addition, brown adipogenesis is an attractive topic from the viewpoint of therapeutic innovation and future research into MSC-based brown adipogenesis could lead to a novel breakthrough. Ongoing stem cell studies and emerging research fields such as epigenetics are expected to elucidate the complicated mechanisms at play in MSC adipogenesis and develop novel MSC-based therapeutic options for obesity. This review discusses the current understanding of MSCs in adipogenesis and their potential clinical applications for obesity.

Duke Scholars

Published In

Lab Invest

DOI

EISSN

1530-0307

Publication Date

October 2017

Volume

97

Issue

10

Start / End Page

1158 / 1166

Location

United States

Related Subject Headings

  • Translational Research, Biomedical
  • Pathology
  • Obesity
  • Mice
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Humans
  • Animals
  • Adipogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Matsushita, K., & Dzau, V. J. (2017). Mesenchymal stem cells in obesity: insights for translational applications. Lab Invest, 97(10), 1158–1166. https://doi.org/10.1038/labinvest.2017.42
Matsushita, Kenichi, and Victor J. Dzau. “Mesenchymal stem cells in obesity: insights for translational applications.Lab Invest 97, no. 10 (October 2017): 1158–66. https://doi.org/10.1038/labinvest.2017.42.
Matsushita K, Dzau VJ. Mesenchymal stem cells in obesity: insights for translational applications. Lab Invest. 2017 Oct;97(10):1158–66.
Matsushita, Kenichi, and Victor J. Dzau. “Mesenchymal stem cells in obesity: insights for translational applications.Lab Invest, vol. 97, no. 10, Oct. 2017, pp. 1158–66. Pubmed, doi:10.1038/labinvest.2017.42.
Matsushita K, Dzau VJ. Mesenchymal stem cells in obesity: insights for translational applications. Lab Invest. 2017 Oct;97(10):1158–1166.

Published In

Lab Invest

DOI

EISSN

1530-0307

Publication Date

October 2017

Volume

97

Issue

10

Start / End Page

1158 / 1166

Location

United States

Related Subject Headings

  • Translational Research, Biomedical
  • Pathology
  • Obesity
  • Mice
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Humans
  • Animals
  • Adipogenesis
  • 3202 Clinical sciences